Single low-dose daratumumab enhances rituximab efficacy for sustained remission in treatment-refractory autoimmune cytopenias
Annals of Hematology · 2026
DOI: 10.1007/s00277-026-07159-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2026. Verfasst von Xiao Long und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Liang Ping People's Hospital of Chongqing, No. 16, Bigui Road, Liangping District, Chongqing, 405200, China. Hauptthemen laut MEDLINE: Rituximab, Cytopenia, Autoimmune Diseases, Antibodies, Monoclonal. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Scientific Research Projects of the Nanan District Health and Wellness Committee and Nanan District Science and Technology Bureau.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Liang Ping People's Hospital of Chongqing, No. 16, Bigui Road, Liangping District, Chongqing, 405200, China.
- Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, No.288, Tian-Wen Road, Chongqing, 400010, China.
- Department of Nephrology, Rheumatology and Hematology, Hami Central Hospital Affiliated to Xinjiang Medical University, No. 10, North Guangchang Road, Yizhou District, Hami City, 839000, China.
- Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, No.288, Tian-Wen Road, Chongqing, 400010, China. 300333@cqmu.edu.cn.
- Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, No.288, Tian-Wen Road, Chongqing, 400010, China. 303774@hospital.cqmu.edu.cn.
Förderung
- the Scientific Research Projects of the Nanan District Health and Wellness Committee and Nanan District Science and Technology Bureau
Zitieren
APA
Long, X., Qin, X., Ke, H., Tang, L., Zhang, Y., Zeng, H., Deng, J., Luo, Y., & Cao, C. (2026). Single low-dose daratumumab enhances rituximab efficacy for sustained remission in treatment-refractory autoimmune cytopenias. Annals of Hematology. https://doi.org/10.1007/s00277-026-07159-x
Vancouver
Long X, Qin X, Ke H, Tang L, Zhang Y, Zeng H, et al. Single low-dose daratumumab enhances rituximab efficacy for sustained remission in treatment-refractory autoimmune cytopenias. Annals of Hematology. 2026. doi:10.1007/s00277-026-07159-x
BibTeX
@article{Long2026,
author = {Long, Xiao and Qin, Xinyi and Ke, Hui and Tang, Li and Zhang, Yanfang and Zeng, Hanqing and Deng, Jianchuan and Luo, Yun and Cao, Chun},
title = {Single low-dose daratumumab enhances rituximab efficacy for sustained remission in treatment-refractory autoimmune cytopenias},
journal = {Annals of Hematology},
year = {2026},
doi = {10.1007/s00277-026-07159-x}
}
EUVIMED